EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases

Experimental Cell Research

Volumn 292, Issue 1, 2004, Pages 201-208

  Guerrero, Javier ^a   Santibañez, Juan Francisco ^a   González, Alfonso ^b,c   Martínez, Jorge ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSIDAD ANDRÉS BELLO   (Chile)

Author keywords

EGFR; Src; Urokinase receptor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MATRIX METALLOPROTEINASE; PROTEIN TYROSINE KINASE; UROKINASE RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOCRINE EFFECT; BREAST CELL; CELL ACTIVITY; CELL PROLIFERATION; CELL STRAIN MCF 7; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0346725841     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2003.08.011     Document Type: Article

References (52)

1. Carpenter G. Employment of the epidermal growth factor receptor in growth factor-independent signaling pathways. J. Cell Biol. 146:1999;697-702.
2. Ossowski L., Aguirre-Ghiso J.A. Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr. Opin. Cell Biol. 12:2000;613-620.
3. Gschwind A., Zwick E., Prenzel N., Leserer M., Ullrich A. Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene. 20:2001;1594-1600.
4. Aguirre Ghiso J.A., Kovalski K., Ossowski L. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J. Cell Biol. 147:1999;89-104.
5. Prenzel N., Zwick E., Leserer M., Ullrich A. Tyrosine kinase signalling in breast cancer. Epidermal growth factor receptor: convergence point for signal integration and diversification. Breast Cancer Res. 2:2000;184-190.
6. Maheshwari G., Wiley H.S., Lauffenburger D.A. Autocrine epidermal growth factor signaling stimulates directionally persistent mammary epithelial cell migration. J. Cell Biol. 155:2001;1123-1128.
7. Andreasen P.A., Kjoller L., Christensen L., Duffy M.J. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer. 72:1997;1-22.
8. Blasi F., Carmeliet P. uPAR: a versatile signalling orchestrator. Nat. Rev., Mol. Cell Biol. 3:2002;932-943.
9. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 61:1990;203-212.
10. Preissner K.T., Kanse S.M., May A.E. Urokinase receptor: a molecular organizer in cellular communication. Curr. Opin. Cell Biol. 12:2000;621-628.
11. Liu D., Aguirre Ghiso J., Estrada Y., Ossowski L. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cells. 1:2002;445-457.
12. Nguyen D.H., Webb D.J., Catling A.D., Song Q., Dhakephalkar A., Weber M.J., Ravichandran K.S., Gonias S.L. Urokinase-type plasminogen activator stimulates the Ras/extracellular signal-regulated kinase (ERK) signaling pathway and MCF-7 cell migration by a mechanism that requires focal adhesion kinase, Src, and Shc. Rapid dissociation of GRB2/Sps-Shc complex is associated with the transient phosphorylation of ERK in urokinase-treated cells. J. Biol. Chem. 275:2000;19382-19388.
13. Nguyen D.H., Hussaini I.M., Gonias S.L. Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility. J. Biol. Chem. 273:1998;8502-8507.
14. Jo M., Thomas K.S., Somlyo A.V., Somlyo A.P., Gonias S.L. Cooperativity between the Ras-ERK and Rho-Rho kinase pathways in urokinase-type plasminogen activator-stimulated cell migration. J. Biol. Chem. 277:2002;12479-12485.
15. Aguirre Ghiso J.A. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Oncogene. 21:2002;2513-2524.
16. Wei Y., Lukashev M., Simon D.I., Bodary S.C., Rosenberg S., Doyle M.V., Chapman H.A. Regulation of integrin function by the urokinase receptor. Science. 273:1996;1551-1555.
17. Wei Y., Yang X., Liu Q., Wilkins J.A., Chapman H.A. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J. Cell Biol. 144:1999;1285-1294.
18. Carriero M.V., Del Vecchio S., Capozzoli M., Franco P., Fontana L., Zannetti A., Botti G., D'Aiuto G., Salvatore M., Stoppelli M.P. Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer. Cancer Res. 59:1999;5307-5314.
19. Xue W., Mizukami I., Todd R.F. III, Petty H.R. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components. Cancer Res. 57:1997;1682-1689.
20. Chapman H.A. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr. Opin. Cell Biol. 9:1997;714-724.
21. Wei Y., Eble J.A., Wang Z., Kreidberg J.A., Chapman H.A. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1. Mol. Biol. Cell. 12:2001;2975-2986.
22. Koshelnick Y., Ehart M., Hufnagl P., Heinrich P.C., Binder B.R. Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J. Biol. Chem. 272:1997;28563-28567.
23. Resnati M., Pallavicini I., Wang J.M., Oppenheim J., Serhan C.N., Romano M., Blasi F. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc. Natl. Acad. Sci. U. S. A. 99:2002;1359-1364.
24. Jo M., Thomas K.S., O'Donnell D.M., Gonias S.L. Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor. J. Biol. Chem. 278:2003;1642-1646.
25. Yarden Y., Sliwkowski M.X. Untangling the ErbB signalling network. Nat. Rev., Mol. Cell Biol. 2:2001;127-137.
26. Hackel P.O., Zwick E., Prenzel N., Ullrich A. Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr. Opin. Cell Biol. 11:1999;184-189.
27. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 402:1999;884-888.
28. Faúndez V., Krauss R., Holuigue L., Garrido J., Gonzalez A. Epidermal growth factor receptor in synaptic fractions of the rat central nervous system. J. Biol. Chem. 267:1992;20363-20370.
29. Salazar G., Gonzalez A. Novel mechanism for regulation of epidermal growth factor receptor endocytosis revealed by protein kinase A inhibition. Mol. Biol. Cell. 13:2002;1677-1693.
30. Ma Z., Webb D.J., Jo M., Gonias S.L. Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells. J. Cell. Sci. 114:2001;3387-3396.
31. Santibáñez J.F., Iglesias M., Frontelo P., Martinez J., Quintanilla M. Involvement of the Ras/MAPK signaling pathway in the modulation of urokinase production and cellular invasiveness by transforming growth factor-beta(1) in transformed keratinocytes. Biochem. Biophys. Res. Commun. 273:2000;521-527.
32. Martinez J., Fuentes M., Cambiazo V., Santibanez J.F. Bone extracellular matrix stimulates invasiveness of estrogen-responsive human mammary MCF-7 cells. Int. J. Cancer. 83:1999;278-282.
33. Pai R., Soreghan B., Szabo I.L., Pavelka M., Baatar D., Tarnawski A.S. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat. Med. 8:2002;289-293.
34. Levenson A.S., Tonetti D.A., Jordan V.C. The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor. Br. J. Cancer. 77:1998;1812-1819.
35. Moro L., Venturino M., Bozzo C., Silengo L., Altruda F., Beguinot L., Tarone G., Defilippi P. Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. EMBO J. 17:1998;6622-6632.
36. Moro L., Dolce L., Cabodi S., Bergatto E., Erba E.B., Smeriglio M., Turco E., Retta S.F., Giuffrida M.G., Venturino M., Godovac-Zimmermann J., Conti A., Schaefer E., Beguinot L., Tacchetti C., Gaggini P., Silengo L., Tarone G., Defilippi P. Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines. J. Biol. Chem. 277:2002;9405-9414.
37. Keely S.J., Calandrella S.O., Barrett K.E. Carbachol-stimulated transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T(84) cells is mediated by intracellular ca(2+), PYK-2, and p60(src). J. Biol. Chem. 275:2000;12619-12625.
38. Prenzel N., Fischer O.M., Streit S., Hart S., Ullrich A. The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr.-Relat. Cancer. 8:2001;11-31.
39. McCole D.F., Keely S.J., Coffey R.J., Barrett K.E. Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factor-alpha. J. Biol. Chem. 277:2002;42603-42612.
40. Giancotti F.G., Ruoslahti E. Integrin signaling. Science. 285:1999;1028-1032.
41. Nguyen D.H., Catling A.D., Webb D.J., Sankovic M., Walker L.A., Somlyo A.V., Weber M.J., Gonias S.L. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J. Cell Biol. 146:1999;149-164.
42. Wilde A., Beattie E.C., Lem L., Riethof D.A., Liu S.H., Mobley W.C., Soriano P., Brodsky F.M. EGF receptor signaling stimulates SRC kinase phosphorylation of clathrin, influencing clathrin redistribution and EGF uptake. Cell. 96:1999;677-687.
43. Tice D.A., Biscardi J.S., Nickles A.L., Parsons S.J. Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc. Natl. Acad. Sci. U. S. A. 96:1999;1415-1420.
44. Chen P., Xie H., Sekar M.C., Gupta K., Wells A. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J. Cell Biol. 127:1994;847-857.
45. Haugh J.M., Schooler K., Wells A., Wiley H.S., Lauffenburger D.A. Effect of epidermal growth factor receptor internalization on regulation of the phospholipase C-gamma1 signaling pathway [In Process Citation]. J. Biol. Chem. 274:1999;8958-8965.
46. Haugh J.M., Huang A.C., Wiley H.S., Wells A., Lauffenburger D.A. Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts. J. Biol. Chem. 274:1999;34350-34360.
47. Wang Y., Pennock S., Chen X., Wang Z. Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival. Mol. Cell. Biol. 22:2002;7279-7290.
48. Sporn M.B., Roberts A.B. Autocrine secretion - 10 years later. Ann. Intern. Med. 117:1992;408-414.
49. Tokumaru S., Higashiyama S., Endo T., Nakagawa T., Miyagawa J.I., Yamamori K., Hanakawa Y., Ohmoto H., Yoshino K., Shirakata Y., Matsuzawa Y., Hashimoto K., Taniguchi N. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J. Cell Biol. 151:2000;209-220.
50. Wasserman J.D., Freeman M. An autoregulatory cascade of EGF receptor signaling patterns the Drosophila egg. Cell. 95:1998;355-364.
51. Foekens J.A., Peters H.A., Look M.P., Portengen H., Schmitt M., Kramer M.D., Brunner N., Janicke F., Meijer-van Gelder M.E., Henzen-Logmans S.C., van Putten W.L., Klijn J.G. The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. Cancer Res. 60:2000;636-643.
52. Del Vecchio S., Stoppelli M.P., Carriero M.V., Fonti R., Massa O., Li P.Y., Botti G., Cerra M., D'Aiuto G., Esposito G.et al. Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. Cancer Res. 53:1993;3198-3206.